合成,体外细胞毒性活性和分子对接研究的androstene和雌激素衍生物
Shailesh Mistry1, Mittal Thakkar2, Akhilesh Kumar Singh3
1Parul Institute of Applied Science, Parul University, P.O. Limbda, Ta. Waghodiya-391760, Vadodara, Gujarat, India.
Steroids
|June 19, 2023
概括
来自雌激素的新型类固醇阿里里丁体显示出作为宫癌的抗癌剂的显著潜力. 这些化合物有效地抑制HT-3细胞系的生长,为癌症治疗提供了有希望的替代方案.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫癌的治疗需要开发新的治疗药物.
- 类固醇化合物为药物发现提供了一个有希望的支架.
研究的目的:
- 为了合成和描述新型类固醇阿里类药物.
- 评估这些化合物对宫癌细胞的体外细胞毒性活性.
- 通过分子对接来研究强效化合物的结合相互作用.
主要方法:
- 克莱森用芳香性化物对安德罗和雌激素进行凝聚.
- 16-arylidene estrone与酸化物的反应.
- 在实验室中对HT-3宫癌细胞系进行细胞毒性测试.
- 分子对接研究,以预测结合亲和关系.
主要成果:
- 合成和鉴定了15种类固醇阿里里丁的特性.
- 对六种化合物的细胞毒性活动进行了评估,显示HT-3细胞系的显著生长抑制.
- 基于雌激素的化合物4a,4b,6b,8c和8d表现出强烈的活性,IC50值低至1.55μM/ml.
- 分子对接研究与体外结果有很好的相关性,表明最强效的化合物具有强大的结合相互作用.
结论:
- 合成的类固醇阿里里丁,特别是以雌激素为基础的类固醇,代表了用于宫癌的新型抗癌药物的有希望的类别.
- 这些发现为开发对宫癌更有效的类固醇药物提供了基础.
- 该研究强调了将合成化学与药物发现的计算方法相结合的潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
800
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
800
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K


